Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.2823 |
| Open | 0.2957 |
| Bid | 0.2601 x 1000 |
| Ask | 0.2518 x 4000 |
| Day's range | 0.2503 - 0.3079 |
| 52-week range | 0.2080 - 1.9700 |
| Volume | |
| Avg. volume | 1,361,304 |
| Market cap | 31.539M |
| Beta (5Y monthly) | 2.03 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.3120 |
| Earnings date | 10 Aug 2022 - 15 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.98 |
- Zacks
Corbus Pharmaceuticals (CRBP) Reports Q1 Loss, Lags Revenue Estimates
Corbus Pharmaceuticals (CRBP) delivered earnings and revenue surprises of 11.11% and 100%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Corcept (CORT) Posts OS Data from Phase II Ovarian Cancer Study
Corcept (CORT) posts overall survival data from a phase II study evaluating relacorilant plus nab-paclitaxel for treating recurrent platinum-resistant ovarian cancer.
- Zacks
Zacks.com featured highlights include Carter's, Target Hospitality, iQIYI, The Buckle, and Corbus Pharmaceuticals
Carter's, Target Hospitality, iQIYI, The Buckle, and Corbus Pharmaceuticals are part of today's Screen of the Week blog.
© 2022 Yahoo. All rights reserved.
